LUNG vs TCMD
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 03, 2026
LUNG
TCMD
Investment Advisor Scores
TCMD
AI Analyst Insights
Detailed Metrics Comparison
| Metric | LUNG | TCMD | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 28.3286 | 19.1205 | TCMD |
| PEG Ratio | 0 | 17.792 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 6.2% | 8.6% | TCMD |
| Earnings Growth | 0.0% | 144.1% | TCMD |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 34.7/100 | 38.2/100 | TCMD |
| Profit Margin | -47.9% | 7.1% | TCMD |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | EXTENDED | AVOID NEW MONEY | LUNG |
Relative Price Performance (Last 90 Days)
Current Technical Phase
LUNG
MarkupPrice above SMA50, rising 50-day trend (0.6% over 20 days), RSI 62
TCMD
NeutralMixed signals - no dominant trend phase, RSI 65
Fundamentals Snapshot
| Metric | LUNG | TCMD |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -3.1 | 18.1 |
| Trailing P/E | — | 25.8 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.1% |
| Gross Margin | 0.8% | 0.8% |
| Operating Margin | -0.3% | 0.1% |
| EPS | -1.01 | 1.03 |
| Dividend Yield | — | — |